Clinical trials
Phase 3 Hypercholesterolemia trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2007 | 1 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2023 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Active, not recruiting | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 5 |
| Kowa Company, Ltd. | 3 |
| Merck Sharp & Dohme LLC | 3 |
| Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 3 |
| Eli Lilly and Company | 2 |
| Sanofi | 2 |
| NewAmsterdam Pharma | 1 |
| Novartis Pharmaceuticals | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 21 |
| Hyperlipidemias | 6 |
| Dyslipidemias | 4 |
| Brain Ischemia | 3 |
| Ischemic Stroke | 3 |
| Recurrence | 3 |
| Stroke | 3 |
| Atherosclerosis | 2 |
| Hyperlipoproteinemia Type II | 2 |
| Arteriosclerosis | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.